Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A7,4 | Lung | Primary cancer | 3,806 | Tumor/Malignant | 50.0% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__87_A7,5 | Lung | Primary cancer | 2,094 | Tumor/Malignant | 34.2% | 0.93 | 0.34 |
| NSCLC_38242124__IMC__87_A7,6 | Lung | Primary cancer | 2,595 | Tumor/Malignant | 25.6% | 0.50 | 0.92 |
| NSCLC_38242124__IMC__87_A7,7 | Lung | Primary cancer | 3,480 | Tumor/Malignant | 31.0% | 0.88 | 0.36 |
| NSCLC_38242124__IMC__87_A7,8 | Lung | Primary cancer | 3,340 | Tumor/Malignant | 44.9% | 0.93 | 0.27 |
| NSCLC_38242124__IMC__87_A7,9 | Lung | Primary cancer | 2,881 | Tumor/Malignant | 39.6% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_A8,10 | Lung | Primary cancer | 5,468 | Tumor/Malignant | 96.8% | 1.00 | 0.00 |
| NSCLC_38242124__IMC__87_A8,11 | Lung | Primary cancer | 359 | Tumor/Malignant | 67.7% | 0.86 | 0.31 |
| NSCLC_38242124__IMC__87_A8,12 | Lung | Primary cancer | 4,213 | Tumor/Malignant | 71.2% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__87_A8,13 | Lung | Primary cancer | 5,888 | Immune | 40.8% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__87_A8,14 | Lung | Primary cancer | 2,819 | Tumor/Malignant | 34.9% | 0.98 | 0.15 |
| NSCLC_38242124__IMC__87_A8,15 | Lung | Primary cancer | 2,151 | Stromal | 40.3% | 0.89 | 0.34 |
| NSCLC_38242124__IMC__87_A8,16 | Lung | Primary cancer | 1,026 | Stromal | 34.0% | 0.48 | 0.79 |
| NSCLC_38242124__IMC__87_A8,17 | Lung | Primary cancer | 2,464 | Tumor/Malignant | 64.4% | 0.95 | 0.13 |
| NSCLC_38242124__IMC__87_A8,2 | Lung | Primary cancer | 3,633 | Tumor/Malignant | 30.6% | 0.97 | 0.18 |
| NSCLC_38242124__IMC__87_A8,3 | Lung | Primary cancer | 3,330 | Tumor/Malignant | 46.0% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__87_A8,4 | Lung | Primary cancer | 3,352 | Tumor/Malignant | 33.4% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A8,5 | Lung | Primary cancer | 3,203 | Tumor/Malignant | 56.5% | 0.96 | 0.18 |
| NSCLC_38242124__IMC__87_A8,6 | Lung | Primary cancer | 3,005 | Tumor/Malignant | 39.1% | 1.00 | 0.05 |
| NSCLC_38242124__IMC__87_A8,7 | Lung | Primary cancer | 3,097 | Tumor/Malignant | 26.7% | 0.58 | 0.76 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A7,4 | Lung | Primary cancer | 3,806 | Tumor/Malignant | 48.5% | 0.95 | 0.13 |
| NSCLC_38242124__IMC__87_A7,5 | Lung | Primary cancer | 2,094 | Tumor/Malignant | 28.8% | 0.96 | 0.25 |
| NSCLC_38242124__IMC__87_A7,6 | Lung | Primary cancer | 2,595 | Tumor/Malignant | 23.0% | 0.51 | 0.92 |
| NSCLC_38242124__IMC__87_A7,7 | Lung | Primary cancer | 3,480 | Tumor/Malignant | 30.2% | 0.69 | 0.69 |
| NSCLC_38242124__IMC__87_A7,8 | Lung | Primary cancer | 3,340 | Tumor/Malignant | 37.6% | 0.95 | 0.20 |
| NSCLC_38242124__IMC__87_A7,9 | Lung | Primary cancer | 2,881 | Tumor/Malignant | 50.3% | 0.98 | 0.12 |
| NSCLC_38242124__IMC__87_A8,10 | Lung | Primary cancer | 5,468 | Tumor/Malignant | 81.9% | 1.00 | 0.00 |
| NSCLC_38242124__IMC__87_A8,11 | Lung | Primary cancer | 359 | Tumor/Malignant | 67.7% | 0.86 | 0.31 |
| NSCLC_38242124__IMC__87_A8,12 | Lung | Primary cancer | 4,213 | Tumor/Malignant | 71.6% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_A8,13 | Lung | Primary cancer | 5,888 | Lymphoid | 25.8% | 0.51 | 0.71 |
| NSCLC_38242124__IMC__87_A8,14 | Lung | Primary cancer | 2,819 | Tumor/Malignant | 29.9% | 0.75 | 0.67 |
| NSCLC_38242124__IMC__87_A8,15 | Lung | Primary cancer | 2,151 | Stromal | 24.3% | 0.75 | 0.59 |
| NSCLC_38242124__IMC__87_A8,16 | Lung | Primary cancer | 1,026 | Other | 28.0% | 0.46 | 0.85 |
| NSCLC_38242124__IMC__87_A8,17 | Lung | Primary cancer | 2,464 | Tumor/Malignant | 54.4% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__87_A8,2 | Lung | Primary cancer | 3,633 | Tumor/Malignant | 30.9% | 0.97 | 0.18 |
| NSCLC_38242124__IMC__87_A8,3 | Lung | Primary cancer | 3,330 | Tumor/Malignant | 46.2% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__87_A8,4 | Lung | Primary cancer | 3,352 | Tumor/Malignant | 33.2% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A8,5 | Lung | Primary cancer | 3,203 | Tumor/Malignant | 43.6% | 0.99 | 0.08 |
| NSCLC_38242124__IMC__87_A8,6 | Lung | Primary cancer | 3,005 | Tumor/Malignant | 42.4% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__87_A8,7 | Lung | Primary cancer | 3,097 | Tumor/Malignant | 23.7% | 0.90 | 0.36 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A7,4 | Lung | Primary cancer | 3,806 | Tumor/Malignant cell | 49.4% | 0.95 | 0.14 |
| NSCLC_38242124__IMC__87_A7,5 | Lung | Primary cancer | 2,094 | Tumor/Malignant cell | 34.1% | 0.92 | 0.35 |
| NSCLC_38242124__IMC__87_A7,6 | Lung | Primary cancer | 2,595 | Tumor/Malignant cell | 38.0% | 0.80 | 0.55 |
| NSCLC_38242124__IMC__87_A7,7 | Lung | Primary cancer | 3,480 | Tumor/Malignant cell | 40.9% | 0.85 | 0.46 |
| NSCLC_38242124__IMC__87_A7,8 | Lung | Primary cancer | 3,340 | Tumor/Malignant cell | 43.5% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__87_A7,9 | Lung | Primary cancer | 2,881 | Tumor/Malignant cell | 56.6% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__87_A8,10 | Lung | Primary cancer | 5,468 | Tumor/Malignant cell | 96.8% | 1.00 | 0.00 |
| NSCLC_38242124__IMC__87_A8,11 | Lung | Primary cancer | 359 | Tumor/Malignant cell | 66.3% | 0.87 | 0.31 |
| NSCLC_38242124__IMC__87_A8,12 | Lung | Primary cancer | 4,213 | Tumor/Malignant cell | 70.8% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__87_A8,13 | Lung | Primary cancer | 5,888 | B cell | 37.2% | 0.49 | 0.89 |
| NSCLC_38242124__IMC__87_A8,14 | Lung | Primary cancer | 2,819 | Tumor/Malignant cell | 37.0% | 0.97 | 0.18 |
| NSCLC_38242124__IMC__87_A8,15 | Lung | Primary cancer | 2,151 | Fibroblast | 40.0% | 0.87 | 0.37 |
| NSCLC_38242124__IMC__87_A8,16 | Lung | Primary cancer | 1,026 | Other | 34.5% | 0.39 | 0.88 |
| NSCLC_38242124__IMC__87_A8,17 | Lung | Primary cancer | 2,464 | Tumor/Malignant cell | 63.9% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_A8,2 | Lung | Primary cancer | 3,633 | Fibroblast | 39.5% | 0.42 | 0.91 |
| NSCLC_38242124__IMC__87_A8,3 | Lung | Primary cancer | 3,330 | Tumor/Malignant cell | 50.8% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__87_A8,4 | Lung | Primary cancer | 3,352 | Tumor/Malignant cell | 33.4% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A8,5 | Lung | Primary cancer | 3,203 | Tumor/Malignant cell | 58.1% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__87_A8,6 | Lung | Primary cancer | 3,005 | Tumor/Malignant cell | 52.8% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A8,7 | Lung | Primary cancer | 3,097 | Tumor/Malignant cell | 38.0% | 0.83 | 0.54 |